Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
BMF (human)

Overview
BMF May play a role in apoptosis. Isoform 1 seems to be the main initiator. Interacts with MCL1, BCL2, BCL2L1/BCL-Xl, BCL2A1 and BCL2L2/BCL-w. Interacts with the myosin V actin motor complex through its binding to DLC2. Isoform 1 is mainly expressed in B-lymphoid cells. Isoform 2 and isoform 3 are mainly expressed in B-CLL and normal B-cells. Belongs to the Bcl-2 family. 3 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Apoptosis; Cytoskeletal protein
Cellular Component: mitochondrial outer membrane; plasma membrane; acrosome; cytosol; myosin complex
Molecular Function: protein binding
Biological Process: positive regulation of protein homooligomerization; apoptosis; anoikis
Reference #:  Q96LC9 (UniProtKB)
Alt. Names/Synonyms: Bcl-2-modifying factor; Bcl2 modifying factor; BMF; FLJ00065
Gene Symbols: BMF
Molecular weight: 20,508 Da
Basal Isoelectric point: 4.91  Predict pI for various phosphorylation states
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

BMF

Protein Structure Not Found.


STRING  |  Wikipedia  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  ENZYME  |  Phospho.ELM  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene


Sites Implicated In
apoptosis, inhibited: S77‑p

Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
3 0 S74-p DKATQTLsPAsPSQG
1 0 S77-p TQTLsPAsPSQGVML
0 1 S109-p YRLPLPAsFPAVLPI
0 1 L114 PAsFPAVLPIGEQPP
  mouse

 
S74-p DKATQTLsPASPSQG
S77 TQTLsPASPSQGVML
S109 YRLPLPASFPAGsPL
S114-p PASFPAGsPLGEQPP
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.